INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 3 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $256,273 | +10.6% | 4,918 | +34.4% | 0.00% | – |
Q2 2023 | $231,688 | +10.5% | 3,659 | -7.5% | 0.00% | – |
Q4 2022 | $209,734 | -27.7% | 3,954 | -56.5% | 0.00% | – |
Q4 2020 | $290,000 | -5.2% | 9,088 | -23.9% | 0.00% | -100.0% |
Q2 2020 | $306,000 | +11.7% | 11,940 | -67.4% | 0.00% | 0.0% |
Q3 2019 | $274,000 | -73.9% | 36,654 | -24.2% | 0.00% | -50.0% |
Q3 2018 | $1,049,000 | +414.2% | 48,357 | +318.1% | 0.00% | – |
Q2 2018 | $204,000 | -89.8% | 11,566 | -87.8% | 0.00% | -100.0% |
Q1 2018 | $1,996,000 | +1132.1% | 94,808 | +783.1% | 0.00% | – |
Q4 2016 | $162,000 | – | 10,736 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |